Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020379

Expand all

CAVERJECT (ALPROSTADIL)
0.01MG/VIAL
Marketing Status: Prescription

Active Ingredient: ALPROSTADIL
Proprietary Name: CAVERJECT
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.01MG/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N020379
Product Number: 001
Approval Date: Jul 6, 1995
Applicant Holder Full Name: PFIZER INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CAVERJECT (ALPROSTADIL)
0.02MG/VIAL
Marketing Status: Prescription

Active Ingredient: ALPROSTADIL
Proprietary Name: CAVERJECT
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.02MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N020379
Product Number: 002
Approval Date: Jul 6, 1995
Applicant Holder Full Name: PFIZER INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CAVERJECT (ALPROSTADIL)
0.04MG/VIAL
Marketing Status: Prescription

Active Ingredient: ALPROSTADIL
Proprietary Name: CAVERJECT
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.04MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N020379
Product Number: 004
Approval Date: May 19, 1997
Applicant Holder Full Name: PFIZER INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CAVERJECT (ALPROSTADIL)
0.005MG/VIAL
Marketing Status: Discontinued

Active Ingredient: ALPROSTADIL
Proprietary Name: CAVERJECT
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.005MG/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020379
Product Number: 003
Approval Date: Jun 27, 1996
Applicant Holder Full Name: PFIZER INC
Marketing Status:  Discontinued
Patent and Exclusivity Information